Ibrance vs Ocrevus
Side-by-side drug price comparison from Medicare Part D data
Verdict
Ibrance costs 54% less per claim than Ocrevus ($10816.00 vs $23635.00). Ibrance has a generic alternative available. Total Medicare spending: Ibrance at $4.5B vs Ocrevus at $3.5B.
| Metric | Ibrance | Ocrevus |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $10,816* | $23,635 |
| Total Medicare Spending Total Medicare Part D spending on this drug | $4.5B | $3.5B |
| Total Claims | 418,000 | 148,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | -5.6%* | 16.5% |
| Generic Available | Yes | Yes |
| Condition | Cancer | Multiple Sclerosis |
| Total Beneficiaries | 36,000 | 62,000 |
Ibrance costs 54% less per claim than Ocrevus ($10816.00 vs $23635.00). Ibrance has a generic alternative available. Total Medicare spending: Ibrance at $4.5B vs Ocrevus at $3.5B.